Harry K Genant
Overview
Explore the profile of Harry K Genant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
5777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Warner S, Kaplan F, Pignolo R, Smith S, Hsiao E, De Cunto C, et al.
Calcif Tissue Int
. 2021 Jul;
109(6):615-625.
PMID: 34331548
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder that leads to heterotopic ossification (HO), resulting in progressive restriction of physical function. In this study, low-dose, whole-body computed tomography (WBCT)...
2.
Tanaka Y, Takeuchi T, Soen S, Yamanaka H, Yoneda T, Tanaka S, et al.
J Rheumatol
. 2021 Apr;
48(11):1663-1671.
PMID: 33858976
Objective: To evaluate the safety and efficacy of long-term denosumab 60 mg every 6 months (Q6M) or every 3 months (Q3M) in patients with rheumatoid arthritis (RA). Methods: This 12-month,...
3.
4.
Watts N, Chesnut 3rd C, Genant H, Harris S, Jackson R, Licata A, et al.
Bone
. 2020 Jan;
134:115222.
PMID: 31911206
Etidronate is a non-nitrogen-containing bisphosphonate. Because it binds with calcium and inhibits crystal formation and dissolution, it was considered by Procter & Gamble as an additive to toothpaste (to prevent...
5.
Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, et al.
Ann Rheum Dis
. 2019 May;
78(7):899-907.
PMID: 31036625
Objective: To evaluate the efficacy of denosumab in suppressing joint destruction when added to conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy in patients with rheumatoid arthritis (RA). Methods: This was...
6.
Ishiguro N, Tanaka Y, Yamanaka H, Yoneda T, Ohira T, Okubo N, et al.
Rheumatology (Oxford)
. 2019 Jan;
58(6):997-1005.
PMID: 30602032
Objectives: To evaluate the efficacy of denosumab for progressive bone erosion in risk factor subgroups of Japanese RA patients. Methods: This study included 340 RA patients on MTX from the...
7.
Kuzma M, Vanuga P, Sagova I, Pavai D, Jackuliak P, Killinger Z, et al.
Eur J Endocrinol
. 2018 Dec;
180(3):201-211.
PMID: 30566903
Introduction Impaired bone microarchitecture is involved in vertebral fracture (VF) development among acromegaly patients. Aim of the study Comparison of DXA-derived bone parameters, areal BMD (aBMD), trabecular bone score (TBS)...
8.
Kroon F, van Beest S, Gandjbakhch F, Peterfy C, Chen S, Conaghan P, et al.
J Rheumatol
. 2018 Dec;
46(9):1228-1231.
PMID: 30554152
Objective: To assess the longitudinal reliability of the Outcome Measures in Rheumatology (OMERACT) Thumb base Osteoarthritis Magnetic resonance imaging (MRI) Scoring system (TOMS). Methods: Paired MRI of patients with hand...
9.
Qin L, Chen C, Genant H, Guo X, Li G, OKeefe R, et al.
J Orthop Translat
. 2018 Apr;
12:A1-A2.
PMID: 29662783
No abstract available.
10.